section name header

Pronunciation

trye-AZ-oh-lam audio

Classifications

Therapeutic Classification: sedative/hypnotics

Pharmacologic Classification: benzodiazepines

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Widely distributed, crosses blood-brain barrier. Probably crosses the placenta and enters breast milk.

Protein Binding: 89%.

Metabolism/Excretion: Metabolized by the liver.

Half-life: 1.6–5.4 hr.

Time/Action Profile

(sedation)

ROUTEONSETPEAKDURATION
PO15–30 min6–8 hrunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: abnormal thinking, behavior changes, dizziness, excessive sedation, hangover, headache, anterograde amnesia, confusion, hallucinations, sleep-driving, lethargy, mental depression, paradoxical excitation.

EENT: blurred vision.

GI: constipation, diarrhea, nausea, vomiting.

Derm: rashes.

Misc: physical dependence, psychological dependence, tolerance.

Interactions

Drug-Drug:

Drug-Natural Products:

Drug-Food:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Halcion

Contr. Subst. Schedule

Schedule IV (C-IV)

Pot. Nursing Diagnoses

Code

NDC Code*